Evidence map›Paper›PMID 26954508›Full record

ArticlePloS one2016

Determinants of Amyloid Formation for the Yeast Termination Factor Nab3.

Thomas W O'Rourke, Daniel Reines

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Thomas W O'RourkeDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Daniel ReinesDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Emory University · US

Funding

RNA POLYMERASE II ELONGATION COMPLEX--STRUCTURE/FUNCTIONR01GM046331 · NIGMS · EMORY UNIVERSITY · PI REINES, DANIEL · 1991 to 2013
$3.5M
Biochemical & Genetic Analysis of Low Complexity Domains in RNA-binding protein biologyR01GM120271 · NIGMS · EMORY UNIVERSITY · PI REINES, DANIEL · 2016 to 2019
$1.3M
FEI Transmission Electron Microscope with Tomography CapabilityS10RR025679 · NCRR · EMORY UNIVERSITY · PI SPEARMAN, PAUL W. · 2009 to 2009
$500k
NCRR NIH HHS S10 RR025679NCRR NIH HHS S10RR025679NIGMS NIH HHS R01 GM046331NIGMS NIH HHS R01 GM120271
6 · The paper itself

Abstract

Low complexity protein sequences are often intrinsically unstructured and many have the potential to polymerize into amyloid aggregates including filaments and hydrogels. RNA-binding proteins are unusually enriched in such sequences raising the question as to what function these domains serve in RNA metabolism. One such yeast protein, Nab3, is an 802 amino acid termination factor that contains an RNA recognition motif and a glutamine/proline rich domain adjacent to a region with structural similarity to a human hnRNP. A portion of the C-terminal glutamine/proline-rich domain assembles into filaments that organize into a hydrogel. Here we analyze the determinants of filament formation of the isolated low complexity domain as well as examine the polymerization properties of full-length Nab3. We found that the C-terminal region with structural homology to hnRNP-C is not required for assembly, nor is an adjacent stretch of 16 glutamines. However, reducing the overall glutamine composition of this 134-amino acid segment from 32% to 14% destroys its polymerization ability. Importantly, full-length wildtype Nab3 also formed filaments with a characteristic cross-β structure which was dependent upon the glutamine/proline-rich region. When full length Nab3 with reduced glutamine content in its low complexity domain was exchanged for wildtype Nab3, cells were not viable. This suggests that polymerization of Nab3 is normally required for its function. In an extension of this idea, we show that the low complexity domain of another yeast termination factor, Pcf11, polymerizes into amyloid fibers and a hydrogel. These findings suggest that, like many other RNA binding proteins, termination factors share a common biophysical trait that may be important for their function.

Indexed as

Amino Acid SequenceAmyloidAmyloidogenic ProteinsMicrobial ViabilityMolecular Sequence DataNuclear ProteinsProtein Aggregation, PathologicalRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsSequence AlignmentAmyloidAmyloidogenic ProteinsNAB3 protein, S cerevisiaeNuclear ProteinsRNA-Binding ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID26954508
PMCPMC4783047
OpenAlexW2299303203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.